Science Market Update

Arizona's BIO5 Institute: Over $1.3M in Grants for Ovarian Cancer Research

Posted by Rebecca Inch-Partridge on Tue, Oct 16, 2018

Ovarian cancer has a mortality rate of up to 70%. This is partly due to the fact that the disease is rarely detected in its early stages because the symptoms are vague and nonspecific. Currently, there is no accepted screening method for ovarian cancer. Due to the mortality rate, physicians often counsel women at high risk to have their ovaries and fallopian tubes removed as a precaution. Jennifer Barton, director of University of Arizona’s BIO5 Institute wants to change all this. With $863,000 from the United States Army and nearly $500,000 from the NIH in research funding, her plans for a falloposcope that will detect early-stage ovarian cancer is moving forward.

Read More

Tags: University of Arizona Tucson, UA, UAZ, Research Funding, Biotech Event, biomedical research, BioResearch Product Faire™, NIH grant, NIH funding, Cancer Diagnostics, cancer research funding, NIDA, cancer research grant, BIO5 Institute, ovarian cancer

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News